AnaptysBio, Inc. (ANAB)
55.05
-1.06
(-1.89%)
USD |
NASDAQ |
Feb 27, 16:00
54.93
-0.12
(-0.22%)
After-Hours: 20:00
AnaptysBio Research and Development Expense (TTM) : 152.43M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Vanda Pharmaceuticals, Inc. | 109.27M |
| Nektar Therapeutics | 116.36M |
| Rigel Pharmaceuticals, Inc. | 28.24M |
| AbbVie, Inc. | 9.096B |
| Esperion Therapeutics, Inc. | 44.90M |